Amish C. Shah, Ph.D.
Affiliations: | 2006 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Microbiology Biology, Oncology, Virology Biology, Medicine and SurgeryGoogle:
"Amish Shah"Parents
Sign in to add mentor| Jacqueline N. Parker | grad student | 2006 | UAB | |
| (Evaluation of novel oncolytic Deltagamma(1)34.5 herpes simplex virus 1 mutants for therapy of malignant glioma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ghonime MG, Jackson J, Shah A, et al. (2017) Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory. Translational Oncology. 11: 86-93 |
| Shah AC, Minturn JE, Li Y, et al. (2015) Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma. Pediatric Blood & Cancer |
| Shah AC, Parker JN, Shimamura M, et al. (2009) Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response. Viruses. 1: 510-22 |
| Shah AC, Parker JN, Gillespie GY, et al. (2007) Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses. Gene Therapy. 14: 1045-54 |
| Shah AC, Price KH, Parker JN, et al. (2006) Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors. Journal of Virology. 80: 7308-15 |
| Shah AC, Benos D, Gillespie GY, et al. (2003) Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. Journal of Neuro-Oncology. 65: 203-26 |